Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: S&P Capital IQ Quantitative Report
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Pure Biosciences Inc Completes Private Placement-Form 8-K

Tuesday, 15 Oct 2013 06:19am EDT 

Pure Biosciences Inc reported in its Form 8-K that on October 14, 2013, PURE Bioscience, Inc. (Company) completed a private placement pursuant to which it sold 2,341,270 shares of its common stock. The shares were sold at a per share purchase price of $0.75 per share, resulting in approximately $1.76 million in aggregate proceeds to the Company. The shares were sold pursuant to a Subscription Agreement under which the Company granted certain registration rights. 

Company Quote

-0.02 -1.94%
18 Sep 2014